Navigation Links
Leading neuroscientist seeks beauty, love and happiness
Date:11/13/2007

One of the world's leading neuroscientists is to search for the neural and biological basis for creativity, beauty and love after receiving over 1 million from the Wellcome Trust, the UK's largest medical research charity. The research will bring together science, the arts and philosophy to answer fundamental questions about what it means to be human.

Professor Semir Zeki from University College London (UCL) has received a Wellcome Trust Strategic Award to establish a programme of research in the new field of "neuroaesthetics". The research will build on his previous work into the neural mechanisms behind beauty(1) and love(2).

Together with Professor Ray Dolan, Director of the Wellcome Trust Centre for Neuroimaging at UCL, Professor Zeki will look at questions that have been debated for millennia by writers, artists and philosophers and yet have been little studied by neurobiologists: Can we measure beauty objectively" How are beauty and love related" What does it mean to be happy"

"All human societies place a high premium on art and the pursuit of beauty," says Professor Zeki. "We all value and reward creativity. We all want to pursue happiness. But what do these entities mean in concrete, neurobiological terms" We hope to address these issues experimentally. The results will not only increase our knowledge about the workings of the human brain but will also give deep insights into human nature and how we view ourselves."

Neuroesthetics aims to illuminate the brain's workings through its cultural products in a similar way to how neuroscientists study the brain through malfunctions caused by disease. However, Professor Zeki believes its impact may be much wider.

"The new field of neuroaesthetics will teach biologists to use the products of the brain in art, music, literature and mathematics to better understand how the brain functions," he says. "Success will encourage an interdisciplinary approach to other fields, such as the study of economics or jurisprudence in terms of brain activity. This will have a deep impact on social issues."

Using Wellcome Trust funding, Professor Zeki hopes to attract students and researchers from the sciences, arts and humanities in truly interdisciplinary research. Their work will be overseen by an Advisory Board that will include author AS Byatt, physician, opera producer and broadcaster Sir Jonathan Miller and Dr. Deborah Swallow, Director of the Courtauld Institute of Art, London.

"Professor Zeki is a Renaissance Man for the twenty-first century," says Professor Richard Morris, Head of Neurosciences and Mental Health at the Wellcome Trust. "His research sees no boundaries between science and the arts and humanities and will provide an exciting insight in issues that strike at the heart of what it is to be human."


'/>"/>

Contact: Craig Brierley
c.brierley@wellcome.ac.uk
44-207-611-7329
Wellcome Trust
Source:Eurekalert

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
4. Leading-edge body sensor could help produce sporting champions
5. Hospital Quality Info on Web Can Be Misleading
6. AT&T Establishes New Network Services for Leading Medical Liability Insurer
7. Video and Photo: Leading CEOs Launch Alliance With American Red Cross to Strengthen Nations Preparedness for Disasters
8. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
9. Sentillion Positioned in Visionaries Quadrant in Leading Industry Analyst Firms User Provisioning Magic Quadrant
10. Leading Asthma and Allergy Author and Counselor Joins The HealthCentral Network As Expert
11. Long Term Care Insurance Gains Momentum Thanks to State Promotions, a Leading Brokerage Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... 27, 2016 , ... More than a third of American adults are considered ... surgery has received increased attention in recent years, as an article published ... weight loss, most people are familiar with the basic requirements of maintaining a healthy ...
(Date:5/27/2016)... ... ... With over 60 percent of acute stroke survivors being left unable to ... in the rehabilitation process has steadily increased. Ekso Bionics had been working to help ... stroke. , Ekso Bionics has now received clearance from the U.S. Food and Drug ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed ... by inspiring human interest stories, courtesy of leaders in the nursing and health ... the industry, from leading advocates and associations—namely Jones & Bartlett Learning. , Jones ...
(Date:5/26/2016)... ... ... There are many ways to cook a hot dog, but new research commissioned ... dogs straight off the grill. Of the 90 percent of Americans who say they ... hot dog, far outpacing other cooking methods such as steaming (12 percent), microwaving (9 ...
(Date:5/26/2016)... , ... May 26, 2016 , ... Connor Sports, ... basketball as a partner for the Tamika Catchings Legacy Tour that will ... industry leader in hardwood basketball surfaces in all forms and levels of the game, ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... MedDay, a biotechnology company focused on the treatment ... "High doses of biotin in progressive multiple sclerosis: extension phase ... Ayman Tourbah , Principal Investigator of the Phase 3 ... Neurology (EAN) in Copenhagen, Denmark . The ... on Sunday, 29 May 2016 from 14:45 to 16:15 CEST ...
(Date:5/24/2016)... --   , ... Endpunkte und demonstriert Ebenbürtigkeit bei der Gesamtreinigung des ... guter , Reinigung des ... (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ) , ... der MORA-Studie der Phase III für NER1006 (1 ...
(Date:5/24/2016)... Celsion Corporation (NASDAQ: CLSN ... an update on its ongoing OVATION study, a ... the Company,s DNA-based immunotherapy, with the standard of ... advanced ovarian cancer who will undergo neoadjuvant chemotherapy ... IL-12 DNA plasmid vector formulated as a nanoparticle ...
Breaking Medicine Technology: